1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > EU5 Haematology Market Outlook to 2021

EU5 Haematology Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 256 pages

EU5 Haematology Market Outlook to 2021

Summary

GlobalData’s new report, "EU5 Haematology Market Outlook to 2021", provides key market data on the EU5 Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the EU5 Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

EU5 Haematology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
2.2 Haematology Market Segmentation 11
2.3 Definitions of Markets Covered in the Report 12
3 Haematology Market, EU5 15
3.1 Haematology Market, EU5, Revenue ($m), 2007-2021 15
3.2 Haematology Market, EU5, Category Comparison by Revenue ($m), 2007-2021 17
3.3 Haematology Market, EU5, Revenue ($m), 2007-2014 19
3.4 Haematology Market, EU5, Revenue ($m), 2014-2021 21
3.5 Haematology Market, EU5, Company Share by Revenue ($m), 2014 23
4 Haematology Market, France 25
4.1 Haematology Market, France, Revenue ($m), 2007-2014 25
4.2 Haematology Market, France, Revenue ($m), 2014-2021 27
4.2.1 Haematology Cell Counters Market, France, Revenue ($m), by Segment, 2007-2014 29
4.2.2 Haematology Rapid Tests and POC Market, France, Revenue ($m), by Segment, 2007-2014 31
4.2.3 Haematology Reagents Market, France, Revenue ($m), by Segment, 2007-2014 33
4.2.4 Haemostasis Market, France, Revenue ($m), by Segment, 2007-2014 35
4.2.5 Immunohaematology Market, France, Revenue ($m), by Segment, 2007-2014 37
4.2.6 Haematology Cell Counters Market, France, Revenue ($m), by Segment, 2014-2021 39
4.2.7 Haematology Rapid Tests and POC Market, France, Revenue ($m), by Segment, 2014-2021 41
4.2.8 Haematology Reagents Market, France, Revenue ($m), by Segment, 2014-2021 43
4.2.9 Haemostasis Market, France, Revenue ($m), by Segment, 2014-2021 45
4.2.10 Immunohaematology Market, France, Revenue ($m), by Segment, 2014-2021 47
4.3 Haematology Market, France, Distribution Share by Revenue ($m), 2013-2014 49
4.4 Haematology Market, France, Company Share by Revenue ($m), 2014 50
5 Haematology Market, Germany 52
5.1 Haematology Market, Germany, Revenue ($m), 2007-2014 52
5.2 Haematology Market, Germany, Revenue ($m), 2014-2021 54
5.2.1 Haematology Cell Counters Market, Germany, Revenue ($m), by Segment, 2007-2014 56
5.2.2 Haematology Rapid Tests and POC Market, Germany, Revenue ($m), by Segment, 2007-2014 58
5.2.3 Haematology Reagents Market, Germany, Revenue ($m), by Segment, 2007-2014 60
5.2.4 Haemostasis Market, Germany, Revenue ($m), by Segment, 2007-2014 62
5.2.5 Immunohaematology Market, Germany, Revenue ($m), by Segment, 2007-2014 64
5.2.6 Haematology Cell Counters Market, Germany, Revenue ($m), by Segment, 2014-2021 66
5.2.7 Haematology Rapid Tests and POC Market, Germany, Revenue ($m), by Segment, 2014-2021 68
5.2.8 Haematology Reagents Market, Germany, Revenue ($m), by Segment, 2014-2021 70
5.2.9 Haemostasis Market, Germany, Revenue ($m), by Segment, 2014-2021 72
5.2.10 Immunohaematology Market, Germany, Revenue ($m), by Segment, 2014-2021 74
5.3 Haematology Market, Germany, Distribution Share by Revenue ($m), 2013-2014 76
5.4 Haematology Market, Germany, Company Share by Revenue ($m), 2014 77
6 Haematology Market, Italy 79
6.1 Haematology Market, Italy, Revenue ($m), 2007-2014 79
6.2 Haematology Market, Italy, Revenue ($m), 2014-2021 81
6.2.1 Haematology Cell Counters Market, Italy, Revenue ($m), by Segment, 2007-2014 83
6.2.2 Haematology Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2007-2014 85
6.2.3 Haematology Reagents Market, Italy, Revenue ($m), by Segment, 2007-2014 87
6.2.4 Haemostasis Market, Italy, Revenue ($m), by Segment, 2007-2014 89
6.2.5 Immunohaematology Market, Italy, Revenue ($m), by Segment, 2007-2014 91
6.2.6 Haematology Cell Counters Market, Italy, Revenue ($m), by Segment, 2014-2021 93
6.2.7 Haematology Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2014-2021 95
6.2.8 Haematology Reagents Market, Italy, Revenue ($m), by Segment, 2014-2021 97
6.2.9 Haemostasis Market, Italy, Revenue ($m), by Segment, 2014-2021 99
6.2.10 Immunohaematology Market, Italy, Revenue ($m), by Segment, 2014-2021 101
6.3 Haematology Market, Italy, Distribution Share by Revenue ($m), 2013-2014 103
6.4 Haematology Market, Italy, Company Share by Revenue ($m), 2014 104
7 Haematology Market, Spain 106
7.1 Haematology Market, Spain, Revenue ($m), 2007-2014 106
7.2 Haematology Market, Spain, Revenue ($m), 2014-2021 108
7.2.1 Haematology Cell Counters Market, Spain, Revenue ($m), by Segment, 2007-2014 110
7.2.2 Haematology Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2007-2014 112
7.2.3 Haematology Reagents Market, Spain, Revenue ($m), by Segment, 2007-2014 114
7.2.4 Haemostasis Market, Spain, Revenue ($m), by Segment, 2007-2014 116
7.2.5 Immunohaematology Market, Spain, Revenue ($m), by Segment, 2007-2014 118
7.2.6 Haematology Cell Counters Market, Spain, Revenue ($m), by Segment, 2014-2021 120
7.2.7 Haematology Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2014-2021 122
7.2.8 Haematology Reagents Market, Spain, Revenue ($m), by Segment, 2014-2021 124
7.2.9 Haemostasis Market, Spain, Revenue ($m), by Segment, 2014-2021 126
7.2.10 Immunohaematology Market, Spain, Revenue ($m), by Segment, 2014-2021 128
7.3 Haematology Market, Spain, Distribution Share by Revenue ($m), 2013-2014 130
7.4 Haematology Market, Spain, Company Share by Revenue ($m), 2014 131
8 Haematology Market, United Kingdom 133
8.1 Haematology Market, United Kingdom, Revenue ($m), 2007-2014 133
8.2 Haematology Market, United Kingdom, Revenue ($m), 2014-2021 135
8.2.1 Haematology Cell Counters Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 137
8.2.2 Haematology Rapid Tests and POC Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 139
8.2.3 Haematology Reagents Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 141
8.2.4 Haemostasis Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 143
8.2.5 Immunohaematology Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 145
8.2.6 Haematology Cell Counters Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 147
8.2.7 Haematology Rapid Tests and POC Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 149
8.2.8 Haematology Reagents Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 151
8.2.9 Haemostasis Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 153
8.2.10 Immunohaematology Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 155
8.3 Haematology Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 157
8.4 Haematology Market, United Kingdom, Company Share by Revenue ($m), 2014 158
9 Overview of Key Companies in EU5 Haematology Market 160
9.1 Siemens Healthcare 160
9.1.1 Company Overview 160
9.2 Sysmex Corporation 160
9.2.1 Company Overview 160
9.3 F. Hoffmann-La Roche Ltd. 160
9.3.1 Company Overview 160
9.4 Horiba, Ltd. 161
9.4.1 Company Overview 161
9.5 Bio-Rad Laboratories, Inc. 161
9.5.1 Company Overview 161
9.6 Danaher Corporation 161
9.6.1 Company Overview 161
9.7 Abbott Laboratories 162
9.7.1 Company Overview 162
9.8 Diagnostica Stago, Inc. 162
9.8.1 Company Overview 162
10 Haematology Market Pipeline Products 163
11 Recent Developments 164
11.1 Corporate Communications 164
11.1.1 Sep 14, 2015: ABCAM: Directorate Changes 164
11.1.2 Jul 27, 2015: Novartis Foundation confirms new members of its Board of trustees, including new Chairman Dr. Joerg Reinhardt 164
11.1.3 Jun 29, 2015: ABCAM Appoints Chief Legal Officer and Company Secretary 165
11.1.4 Jun 15, 2015: Intra-Cellular Therapies Reports Completion of Enrollment With 450 Patients Randomized in the ITI-007-301 Phase 3 Clinical Trial for the Treatment of Schizophrenia 166
11.1.5 May 08, 2015: Change in Roche Board of Directors 167
11.1.6 Mar 19, 2015: Novartis To Eliminate 89 Jobs At Suffern Facility 167
11.1.7 Dec 12, 2014: Abcam Announces Board Appointment 167
11.1.8 Nov 18, 2014: Ablynx Appoints Johan Heylen As Chief Commercial Officer 168
11.1.9 Oct 30, 2014: Novartis Lays Off 75 Employees At Lincoln Plant 168
11.2 Financial Announcements 168
11.2.1 Sep 16, 2015: WaferGen Presents Results From Company's Single-Cell System at the Single Cell Genomics Meeting 168
11.2.2 Sep 14, 2015: ABCAM: Preliminary Results for the Year Ended 30 June 2015` 170
11.2.3 Aug 27, 2015: Ablynx Announces Half-Year Results For 2015 174
11.2.4 Jul 23, 2015: Roche delivers strong performance in the first half of 2015 176
11.2.5 Jun 04, 2015: Roche receives FDA clearance for the cobas Cdiff Test to detect Clostridium difficile 177
11.2.6 Apr 23, 2015: Novartis delivered sales growth, significant margin expansion and strong innovation in Q1; now with a more focused portfolio 178
11.2.7 Apr 22, 2015: Roche reports strong sales growth in the first quarter of 2015 185
11.2.8 Apr 01, 2015: BTG begins sale of DC Bead and Bead Block directly to Physicians 189
11.2.9 Mar 30, 2015: 100th Patent in Three Years: The Result of a Successful Patent Strategy 192
11.2.10 Mar 09, 2015: Abcam: Interim Results for the Six Months Ended 31 December 2014 193
11.2.11 Feb 26, 2015: Ablynx Announces 2014 Full Year Results 194
11.2.12 Feb 26, 2015: Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014 197
11.2.13 Jan 27, 2015: Novartis Reports Finanical Results for Fourth Quarter of 2014 200
11.2.14 Jan 26, 2015: Heat Biologics Presents Positive Immunological Data on HS-410 in Non-Muscle Invasive Bladder Cancer at the 7th Annual Phacilitate Immunotherapy Forum 2015 209
11.2.15 Jan 26, 2015: Ipsen announces topline results of two double-blind phase III studies of Dysport in lower limb spasticity in children and in adults 211
11.2.16 Nov 13, 2014: Ablynx Announces Its Business Update For The First Nine Months Of 2014 213
11.2.17 Nov 04, 2014: Grifols Net Profit Increases By 26.9% To 339 Million Euros In The Nine Months To September 2014 215
11.2.18 Oct 28, 2014: Novartis delivered solid sales growth with strong margin expansion and major innovation in the third quarter 219
11.3 Legal And Regulatory 229
11.3.1 Feb 16, 2015: Grifols PhocusRx Certified DIACAP Compliant 229
11.3.2 Jan 22, 2015: Ablynx Successfully Opposes Patent Appeal Case By Domantis 229
11.3.3 Jan 21, 2015: Grifols Academy of Plasmapheresis Awarded ACCET Accreditation 230
11.3.4 Jan 02, 2015: Grifols new immunoglobulin purification plant in the United States receives FDA approval 231
11.4 Other Significant Developments 232
11.4.1 Sep 11, 2015: For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 232
11.4.2 Jul 21, 2015: Novartis delivered solid performance in the second quarter, with strong innovation and progress on new launches 232
11.4.3 Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche 240
11.4.4 Oct 02, 2014: Siemens, Inpeco and Quest Diagnostics Join Forces to Build the Lab of the Future 241
11.5 Product News 242
11.5.1 Jun 22, 2015: Roche unveils powerful innovations in diagnostics at EuroMedLab 242
11.5.2 Mar 18, 2015: Tumour determination in bowel cancer: blood test replaces surgery 243
11.5.3 Dec 16, 2014: Irish company at advanced stage of testing a treatment for Ebola 244
11.5.4 Nov 13, 2014: Randox Launches Data Management Advisor To Optimise Lab Quality Control 244
11.6 Strategy And Business Planning 245
11.6.1 Aug 12, 2015: CINDE Announces Pharmaceutical Invested $5.5 Million for New Headquarters 245
11.6.2 Jul 07, 2015: Shionogi Announces the Continued Expansion of their Operations in Europe with the Launch of Shionogi Italy 246
11.6.3 Jul 01, 2015: Roche lays foundation stone of new IT innovation centre in Kaiseraugst 247
11.6.4 Jun 30, 2015: ISD completes single envelope ‘clad rack' cold storage facility for Spanish pharmaceutical giant Grifols 247
11.6.5 Jan 19, 2015: Roche opens new Learning Center in Kaiseraugst 248
11.6.6 Jan 17, 2015: Novartis To Shutdown Manufacturing Facility In Puerto Rico 249
11.6.7 Jan 14, 2015: Randox Strengthens Regional Commitment with Expansion Plans in County Antrim 249
11.6.8 Nov 27, 2014: Diagnostics Leader Delivers New Fertility Service For UK 250
11.6.9 Oct 20, 2014: Randox Teoranta sets out new vision with Dungloe 2020 251
12 Appendix 253
12.1 Research Methodology 254
12.1.1 Coverage 254
12.1.2 Secondary Research 254
12.1.3 Primary Research 254
12.1.4 Company Share Analysis 255
12.1.5 Distribution Share Analysis 255
12.2 GlobalData Consulting 255
12.3 Contact Us 255
12.4 Disclaimer 256

1.1 List of Tables
Table 1: Haematology Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021 16
Table 2: Haematology Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021 18
Table 3: Haematology Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014 20
Table 4: Haematology Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021 22
Table 5: Haematology Market, EU5, Company Share by Revenue ($m), USD Constant, 2014 24
Table 6: Haematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 26
Table 7: Haematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Table 8: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 30
Table 9: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 32
Table 10: Haematology Reagents Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 34
Table 11: Haemostasis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 36
Table 12: Immunohaematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 38
Table 13: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Table 14: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 42
Table 15: Haematology Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 44
Table 16: Haemostasis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Table 17: Immunohaematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 18: Haematology Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 49
Table 19: Haematology Market, France, Company Share by Revenue ($m), USD Constant, 2014 51
Table 20: Haematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 53
Table 21: Haematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Table 22: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 57
Table 23: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 59
Table 24: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 61
Table 25: Haemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 63
Table 26: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 65
Table 27: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Table 28: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Table 29: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Table 30: Haemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 73
Table 31: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 75
Table 32: Haematology Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 76
Table 33: Haematology Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 78
Table 34: Haematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 80
Table 35: Haematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 82
Table 36: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 84
Table 37: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 86
Table 38: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 88
Table 39: Haemostasis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 90
Table 40: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 92
Table 41: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Table 42: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Table 43: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Table 44: Haemostasis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 100
Table 45: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 102
Table 46: Haematology Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 103
Table 47: Haematology Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 105
Table 48: Haematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 107
Table 49: Haematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 109
Table 50: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 111
Table 51: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 113
Table 52: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 115
Table 53: Haemostasis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 117
Table 54: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 119
Table 55: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 121
Table 56: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 123
Table 57: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 125
Table 58: Haemostasis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 127
Table 59: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 129
Table 60: Haematology Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 130
Table 61: Haematology Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 132
Table 62: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 134
Table 63: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Table 64: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 138
Table 65: Haematology Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 140
Table 66: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 142
Table 67: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 144
Table 68: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 146
Table 69: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 148
Table 70: Haematology Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 150
Table 71: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 152
Table 72: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Table 73: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Table 74: Haematology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 157
Table 75: Haematology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 159
Table 76: Haematology Market Pipeline Products 163

1.2 List of Figures
Figure 1: Haematology Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021 15
Figure 2: Haematology Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021 17
Figure 3: Haematology Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014 19
Figure 4: Haematology Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021 21
Figure 5: Haematology Market, EU5, Company Share (%) 2014 23
Figure 6: Haematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 25
Figure 7: Haematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Figure 8: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 29
Figure 9: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 31
Figure 10: Haematology Reagents Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 33
Figure 11: Haemostasis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 35
Figure 12: Immunohaematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 37
Figure 13: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Figure 14: Haematology Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Figure 15: Haematology Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 43
Figure 16: Haemostasis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Figure 17: Immunohaematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 18: Haematology Market, France, Company Share (%) 2014 50
Figure 19: Haematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 52
Figure 20: Haematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Figure 21: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 56
Figure 22: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 58
Figure 23: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 60
Figure 24: Haemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 62
Figure 25: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 64
Figure 26: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 66
Figure 27: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Figure 28: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 70
Figure 29: Haemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 72
Figure 30: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 74
Figure 31: Haematology Market, Germany, Company Share (%) 2014 77
Figure 32: Haematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 79
Figure 33: Haematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 81
Figure 34: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 83
Figure 35: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 85
Figure 36: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 87
Figure 37: Haemostasis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 89
Figure 38: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 91
Figure 39: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Figure 40: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Figure 41: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Figure 42: Haemostasis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Figure 43: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 101
Figure 44: Haematology Market, Italy, Company Share (%) 2014 104
Figure 45: Haematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 106
Figure 46: Haematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Figure 47: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 110
Figure 48: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 112
Figure 49: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 114
Figure 50: Haemostasis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 116
Figure 51: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 118
Figure 52: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 120
Figure 53: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 122
Figure 54: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 124
Figure 55: Haemostasis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 126
Figure 56: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 128
Figure 57: Haematology Market, Spain, Company Share (%) 2014 131
Figure 58: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 133
Figure 59: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Figure 60: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 137
Figure 61: Haematology Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 139
Figure 62: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 141
Figure 63: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 143
Figure 64: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 145
Figure 65: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 147
Figure 66: Haematology Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 149
Figure 67: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 151
Figure 68: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 153
Figure 69: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Figure 70: Haematology Market, United Kingdom, Company Share (%) 2014 158

Companies mentioned
Siemens Healthcare
Sysmex Corporation
F. Hoffmann-La Roche Ltd.
Horiba, Ltd.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Abbott Laboratories
Diagnostica Stago, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

  • $ 7500
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.